Use of Rituximab in Pediatric Nephrology: A Bibliometric and Visualization Analysis from 2003 to 2024
This study reveals a consistent increase in publication output and citation frequency in this field from 2003 to 2024, highlighting the significant impact of RTX in the global arena of pediatric renal disease treatment. These findings not only offer researchers a rapid grasp of current research hotspots but also provide a basis for predicting future research trends, further supporting the potential and significance of RTX in the treatment of pediatric renal diseases.
Authors
- S.K. Yu (ORCID: https://orcid.org/0000-0001-8300-7109)
- Haihua Tan
Institutions
- Guangdong Medical College (CN)
- Guangzhou First People's Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Critical Reviews in Eukaryotic Gene Expression
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1615/critreveukaryotgeneexpr.2025061540
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00